Sirolimus(Fyarro, Hyftor, Rapamune)

C₅₁H₇₉NO₁₃

dual anti-CD19/anti-CD22 CAR T-cell therapy

Solid Tumors (Dynamic Cell Therapies)

solid tumors therapy

CAR-NK cell therapy (solid tumors)

T-cell therapy (GEiGS, solid Tumors)

dual anti-CD19/anti-CD20 CAR T-cell therapy

CLK3 inhibitor (oral, solid tumors), Biosplice Therapeutics

CLK2 inhibitor (oral, solid tumors), Biosplice Therapeutics

anti-MUC1 CAR T-cell therapy